(Q46885835)

English

Intravitreal triamcinolone and bevacizumab combination therapy for refractory choroidal neovascularization with retinal angiomatous proliferation

scientific article published on 23 November 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18034193

Intravitreal triamcinolone and bevacizumab combination therapy for refractory choroidal neovascularization with retinal angiomatous proliferation (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18034193

1 reference

based on heuristic

inferred from title

neovascularization

1 reference

based on heuristic

inferred from title

author name string

S J Bakri

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18034193

N S Ekdawi

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18034193

publication date

23 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18034193

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18034193

22

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18034193

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18034193

978-980

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18034193

Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703041

21 January 2018

Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703041

21 January 2018

Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703041

21 January 2018

Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703041

7 January 2021

based on heuristic

inferred from DOI database lookup

Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703041

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.EYE.6703041

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18034193

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18034193

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46885835&oldid=2208212010"